As of May 2024 T2 Biosystems has a market cap of $26.81 Million. This makes T2 Biosystems the world's 7921th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $26.81 M | 5.52% |
2023 | $25.41 M | 144.54% |
2022 | $10.39 M | -87.87% |
2021 | $85.67 M | -53.3% |
2020 | $0.18 B | 209.58% |
2019 | $59.26 M | -55.43% |
2018 | $0.13 B | -9.91% |
2017 | $0.14 B | -7.79% |
2016 | $0.16 B | -39.48% |
2015 | $0.26 B | -31.41% |
2014 | $0.38 B |
On May 8th, 2024 the market cap of T2 Biosystems was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Aldeyra Therapeutics
ALDX | $0.24 B | 801.68% | ๐บ๐ธ USA |
CareDx CDNA | $0.52 B | 1,874.17% | ๐บ๐ธ USA |